Search
for
Sort by
Research 331–360 of 1000+
- Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Characterization of DNA Methylation and Screening of Epigenetic Markers in Polycystic Ovary Syndrome
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Volume imaging to interrogate cancer cell-tumor microenvironment interactions in space and time
- Global Trends in Research of Androgen Receptor Associated With Breast Cancer From 2011 to 2020: A Scientometric Analysis
- Ottawa, Ontario, Canada, February 13–16, 2013
- Advances of Microneedles for Cancer Diagnosis and Therapy
- Aldosterone- and cortisol-cosecreting adrenal adenoma, ovarian hyperthecosis and breast cancer
- An assessment of curcumin, curcumin spanlastics nanoparticles, and curcumin nanocrystals as possible drug delivery systems with antimicrobial, antioxidant, and antitumor activities
- Research advances of tissue-derived extracellular vesicles in cancers
- Sorting Out the Seeming Increase in Lung Cancer in Women Who Have Never Smoked
- Three-Dimensional-Bioprinted Non-Small Cell Lung Cancer Models in a Mouse Phantom for Radiotherapy Research
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
- Transcription Regulation and Protein Subcellular Localization of the Truncated Basic Hair Keratin hHb1-ΔN in Human Breast Cancer Cells
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Fully automated chip-based nanoelectrospray ionization-mass spectrometry as an effective tool for rapid and high-throughput screening of 5α-reductase inhibitors
- Amphiregulin in Fibrotic Diseases and Cancer
- Advancing Design Strategy of PROTACs for Cancer Therapy
- Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: Myosin light chain kinase and caldesmon
- Amphiregulin in Fibrotic Diseases and Cancer
- Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Environmental factors influencing hormone receptor positive breast cancer incidence: integrating chemical signatures from dust wipes with self-reported sources of exposure
- Review of Drug Repositioning in Cancer Therapeutics
- Virtual Insights into Natural Compounds as Potential 5α-Reductase Type II Inhibitors: A Structure-Based Screening and Molecular Dynamics Simulation Study
- Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer